Posts Tagged: National Institutes of Health


Commenters on Bayh-Dole Rule Object to Mention of ‘Pricing’ in March-In Provision

Two organizations with which I work have filed comments with NIST on its Bayh-Dole regulatory proposals. The National Institute of Standards and Technology, or NIST, approaches completion …
By James Edwards
8 months ago 2

A Swing (and a Miss) at NIH Tech Transfer

How many people or organizations could undergo an exhaustive investigation into everything they've done over the past 30 years and emerge unscathed? That's what just happened to the …
By Joseph Allen
1 year ago 0

A Misguided Op-Ed, a Key Report, and Why Holding the U.S. Lead in the Life Sciences is More Important Than Ever

Our current experiences with COVID-19 in the United States, together with headlines warning of major efforts by the Chinese and Russian governments to hack corporate, academic and …
By Joseph Allen
1 year ago 6

Stand Up to the Anti-Patent COVID-19 Narrative

It may seem odd, as unprecedented public/private sector R&D alliances work to discover and develop therapies to counter COVID-19, that some are trying to punish …
By Joseph Allen
2 years ago 4

Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them

The world is teetering on the brink of a public health and economic catastrophe, depending on emergency partnerships between our public and private sectors to develop a …
By Joseph Allen
2 years ago 41

Don’t Undermine the Policies Most Likely to Solve the Coronavirus Crisis

To say that the world's been deeply shaken by the coronavirus (and the disease it causes, known as COVID-19) is no exaggeration. Our stock market has plunged, …
By Joseph Allen
2 years ago 2

Links to China Prompt Purge at Moffitt Cancer Center

Underscoring the seriousness of the threat posed by the Chinese government's campaign to obtain results of U.S. publicly funded research, the Board of Directors at the …
By Joseph Allen
2 years ago 15

U.S. Government Patent Enforcement: A Ripple or a Coming Tempest?

In most respects, the widely reported patent complaint recently filed against Gilead is perfectly ordinary. It was filed in the U.S. District Court for the District …

This Week in Washington IP: House IP Subcommittee to Hold Hearing on Arthrex; Other Committees Consider Flu Vaccine Innovation, FCC Spectrum Auction Oversight

This week in Washington, D.C., the House Intellectual Property Subcommittee will explore the  impact of the Federal Circuit’s recent Arthrex decision on the Patent Trial …
By IPWatchdog
2 years ago 0

Will Bayh-Dole Survive Its 40th Birthday?

Next year marks the 40th anniversary of the passage of the Bayh-Dole Act. With election day looming, 2020 is likely to be the most politically contentious year of …
By Joseph Allen
2 years ago 1

This Week in D.C.: Competition in Digital Tech Markets, NIH Medical Research Funding and Clean Industrial Innovation

This week in the U.S. capital, the Senate will hold committee hearings on antitrust issues in digital platforms and real-time payment systems, a sector of fintech …
By IPWatchdog
2 years ago 0

The ‘Dragon’ Targets U.S. Biopharma Lead

Perhaps the report on China's strategy for eclipsing the U.S. lead in biopharma from the Information Technology & Innovation Foundation (ITIF) resonated so strongly with me because …
By Joseph Allen
2 years ago 2

Bayh-Dole Rocks While the Critics Play the Same False Note

A just-released study co-sponsored by the Biotechnology Innovation Organization (BIO) and AUTM provides new evidence of the significant contribution academic patent licensing makes to the U.S. …
By Joseph Allen
2 years ago 0

The Washington Post Misses the Mark on March-In Rights

The National Institute of Standards and Technology recently indicated in its "Return on Investment Initiative draft green paper" that it would issue regulations effectively ending attempts to …
By Joseph Allen
3 years ago 2

IP and Innovation on Capitol Hill: Week of April 1: Medicare Drug Pricing, Lost Einsteins and Data Privacy

This week on Capitol Hill will include a series of hearings related to tech and innovation topics on Tuesday at the House of Representatives, where debate will …
By IPWatchdog
3 years ago 0